Answers are grounded in this paper and cite their sources.
We report the development and characterization of compound 22 (MK-5046), a potent, selective small molecule agonist of BRS-3 (bombesin receptor subtype-3). In pharmacological testing using diet-induced obese mice, compound 22 caused mechanism-based, dose-dependent reductions in food intake and body weight.
No takes yet. Share an insight, caveat, or question.
Sebhat et al. (2010) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: